Xponance Inc. Has $6.23 Million Stake in Mettler-Toledo International, Inc. (NYSE:MTD)

Xponance Inc. boosted its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 15.9% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 5,276 shares of the medical instruments supplier's stock after acquiring an additional 724 shares during the quarter. Xponance Inc.'s holdings in Mettler-Toledo International were worth $6,230,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Raymond James Financial Inc. bought a new position in shares of Mettler-Toledo International in the 4th quarter valued at about $9,145,000. Sequoia Financial Advisors LLC boosted its stake in shares of Mettler-Toledo International by 10.4% in the 4th quarter. Sequoia Financial Advisors LLC now owns 616 shares of the medical instruments supplier's stock valued at $753,000 after purchasing an additional 58 shares during the last quarter. EverSource Wealth Advisors LLC boosted its stake in shares of Mettler-Toledo International by 28.8% in the 4th quarter. EverSource Wealth Advisors LLC now owns 152 shares of the medical instruments supplier's stock valued at $186,000 after purchasing an additional 34 shares during the last quarter. Farther Finance Advisors LLC boosted its stake in shares of Mettler-Toledo International by 14.3% in the 4th quarter. Farther Finance Advisors LLC now owns 64 shares of the medical instruments supplier's stock valued at $78,000 after purchasing an additional 8 shares during the last quarter. Finally, Skandinaviska Enskilda Banken AB publ boosted its stake in shares of Mettler-Toledo International by 77.6% in the 4th quarter. Skandinaviska Enskilda Banken AB publ now owns 10,485 shares of the medical instruments supplier's stock valued at $12,791,000 after purchasing an additional 4,581 shares during the last quarter. Institutional investors own 95.07% of the company's stock.

Analyst Ratings Changes

Several research analysts have recently issued reports on the stock. Jefferies Financial Group raised shares of Mettler-Toledo International from an "underperform" rating to a "hold" rating and reduced their target price for the company from $1,200.00 to $1,110.00 in a research note on Monday, May 5th. Robert W. Baird reduced their target price on shares of Mettler-Toledo International from $1,369.00 to $1,034.00 and set a "neutral" rating on the stock in a research note on Tuesday, April 22nd. Wall Street Zen lowered shares of Mettler-Toledo International from a "buy" rating to a "hold" rating in a research note on Monday, May 5th. Bank of America lifted their price objective on shares of Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the stock a "neutral" rating in a research note on Thursday, June 26th. Finally, Wells Fargo & Company lifted their price objective on shares of Mettler-Toledo International from $1,125.00 to $1,200.00 and gave the stock an "equal weight" rating in a research note on Monday, May 5th. Seven research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, Mettler-Toledo International presently has an average rating of "Hold" and an average price target of $1,280.90.

Insider Activity

In other news, Director Michael A. Kelly sold 1,062 shares of Mettler-Toledo International stock in a transaction that occurred on Wednesday, May 28th. The shares were sold at an average price of $1,159.93, for a total value of $1,231,845.66. Following the sale, the director directly owned 120 shares in the company, valued at $139,191.60. This trade represents a 89.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.77% of the stock is owned by company insiders.

Mettler-Toledo International Price Performance

Shares of MTD traded up $15.15 during midday trading on Wednesday, hitting $1,183.71. The stock had a trading volume of 202,761 shares, compared to its average volume of 151,114. The company has a 50 day simple moving average of $1,169.38 and a two-hundred day simple moving average of $1,194.46. Mettler-Toledo International, Inc. has a twelve month low of $946.69 and a twelve month high of $1,546.93. The firm has a market cap of $24.60 billion, a price-to-earnings ratio of 29.52, a price-to-earnings-growth ratio of 3.67 and a beta of 1.37.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The medical instruments supplier reported $8.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.90 by $0.29. Mettler-Toledo International had a negative return on equity of 556.22% and a net margin of 22.17%. The firm had revenue of $883.74 million for the quarter, compared to the consensus estimate of $876.61 million. During the same quarter last year, the business posted $8.89 EPS. The company's revenue for the quarter was down 4.6% on a year-over-year basis. Analysts forecast that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.